Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 10 Reduced Inequalities -
SDG 17 Partnerships for the Goals
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF NXT007 PROPHYLAXIS VERSUS FACTOR VIII PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A WITHOUT INHIBITORS
Reding, M. T. (PI)
HOFFMANN-LA ROCHE PHARMACEUTICALS
12/10/25 → 12/9/36
Project: Research project
-
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF NXT007 PROPHYLAXIS VERSUS EMICIZUMAB PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A
Reding, M. T. (PI)
HOFFMANN-LA ROCHE PHARMACEUTICALS
12/10/25 → 12/9/36
Project: Research project
-
A New Risk-Based Scoring Approach to Individualize Prophylaxis in Patients with Hemophilia A: Results from the PREDICT Study
Quon, D. V., Escobar, M., Boggio, L., Corrales-Medina, F. F., Jain, A., Reding, M. T., Sidonio, R. F., Staber, J. M. & Charlet, J., Jul 2026, In: Advances in Therapy. 43, 7, p. 2913-2929 17 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing HEM-POWR Study
Reding, M. T., Alvarez Román, M. T., Castaman, G., Janbain, M., Matsushita, T., Meijer, K., Schmidt, K. & Oldenburg, J., Feb 2026, In: European Journal of Haematology. 116, 2, p. 148-159 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study
Chrisentery-Singleton, T., Acharya, S., Ahuja, S., Amos, L. E., Chitlur, M., Daoud, N., Eason, A., Escobar, M., Fedor, C., Gupta, S., Kuriakose, P., Nasr, S., Pennington, S., Pruthi, R. K., Recht, M., Robertson, A., Quon, D. V., Wheeler, A. P. & Reding, M., Aug 2026, In: Blood Vessels, Thrombosis and Hemostasis. 3, 3, 100169.Research output: Contribution to journal › Article › peer-review
Open Access -
Characterization and management of patients with hereditary factor X deficiency: A case series
Chitlur, M., Amos, L. E., Reding, M. T., Sabo, C. & Acharya, S. S., Oct 2025, In: Transfusion. 65, 10, p. 1786-1792 7 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Correction to: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review (Drugs in R&D, (2024), 24, 3, (359-381), 10.1007/s40268-024-00481-7)
Reding, M. T., Lalezari, S., Kenet, G., Di Minno, G., Ducore, J., Solms, A., Shah, A., Holme, P. A., Poulsen, L. H., Meijer, K., Simpson, M. & Mancuso, M. E., Mar 2025, In: Drugs in R and D. 25, 1, p. 89-98 10 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access